Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease

BMJ

Volumn 310, Issue 6980, 1995, Pages 627-

  Van Duijn, Cornelia M ^a   Havekes, Louis M ^b   Van Broeckhoven, Christine ^c   de Knijff, Peter ^b   Hofman, Albert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ONSET AGE; PRIORITY JOURNAL; SMOKING;

AGE OF ONSET; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; NETHERLANDS; ODDS RATIO; POPULATION SURVEILLANCE; RISK FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0028986481     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.310.6980.627     Document Type: Article

References (26)

1. Van Duijn CM Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ 1991; 302: 1491–4.
2. Graves AB Van Duijn CM Chandra V Fratiglioni L Heyman A Jorm AF, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20(suppl 2):S48–57.
3. Brenner DE Kukull WA van Belle G Bowen JD McCormick WC Teri L, et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993; 43: 293–300.
4. Riggs JE. Smoking and Alzheimer's disease: protective effect or differential bias? Lancet 1993; 342: 793–4.
5. Hardy J Roberts GW. Smoking and neurogenerative disease (letter). Lancet 1993; 342: 1238.
6. Larrick JW Wright SC. Smoking and neurogenerative disease (letter). Lancet 1993; 342: 1238–9.
7. Ben-Shlomo Y. Smoking and neurodegenerative disease (letter). Lancet 1993; 342: 1239.
8. Morens DM Grandinetti A Reed D White LR. Smoking-associated protection from Alzheimer's and Parkinson's disease. Lancet 1993; 343: 356–7.
9. Davignon J Gregg RE Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1–21.
10. Strittmatter WJ Saunders AM Schmechel D Pericak-Vance M Enghild J Salvesen GS, et al. Apolipoprotein E: high avidity binding to (beta) amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci 1993; 90: 1977–81.
11. Saunders AM Strittmatter WJ Schmechel D St George-Hyslop P Pericak-Vance MA Joo SH, et al. Association of apolipoprotein E allele e4 with lateonset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–72.
12. Chartier-Harlin MC Parifitt M Legrain S Perez-Tur J Brousseau T Evans A, et al. Apolipoprotein E, e4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994; 3: 569–74.
13. Van Duijn Cm de Knijff P Cruts M Wehnert A Havekes LM Hofman A, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994; 1: 74–8.
14. Hofman A Schulte W Tanja TA van Duijn CM Haaxma R Otten VM, et al. History of dementia and Parkinson's disease in first degree relatives of patients with Alzheimer's disease. Neurology 1989; 39: 1589–92.
15. McKhann G Drachman D Foilstein M Katzman R Price D Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group. Neurology 1984; 34: 939–44.
16. Hofman A Grobbee DE DeJong PTVM Vandenouweland FA. Determinants of disease and disability in the elderly. The Rotterdam elderly study. Eur J Epidemiol 1991; 7: 403–22.
17. Folstein MF Folstein SE McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
18. Wenham PR Price WH Blundell G. Apolipoprotein E genotyping by onestage PCR. Lancet 1991; 337: 1158–9.
19. Havekes LM de Knijff P Beisiegel U Havinga J Smit M Klasen E. A rapid micro-method for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987; 28: 445–63.
20. Elston RC Johnson WD. Essentials of biostatistics. Philadelphia: Davis, 1987.
21. Breslow NE Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. Lyons: International Agency for Research on Cancer, 1987. Scientific publications No 82.
22. Hachinski VC Iliff LD Zilhka E Du Boulay GH McAllister VL Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632–7.
23. Poirier I Aubert I Dea D Quirion R. Apolipoprotein E4 and cholinergic dysfunction in Alzheimer's disease. In: GiacobiniE(Ed). Proceedings of Springfield meeting on Alzheimer disease. Cambridge, MA: Birkhauser Boston, 1994: 72–6.
24. Benwell ME Balfour DJK Anderson JM. Evidence that tobacco smoke increases the density of (-)-(3H) nicotine binding sites in human brain. J Neurochem 1988; 50: 1243–7.
25. Strittmatter WJ Weisgraber KH Huang DY Dong LM Salvesen GS Pericak-Vance MA, et al. Binding of human apolipoprotein E to synthetic amyloid (beta) peptide: isoform-specific effects and implications for late-onset familial Alzheimer's disease. Proc Natl Acad Sci 1993; 90: 8098–102.
26. Calne DB Langston JW. Aetiology of Parkinson's disease. Lancet 1983; ii: 1457–79.